The alliance is carried out within the framework of an agreement signed in October 2023 between the Reloncaví Health Service – National Health Fund (Fonasa) and the Institute of Nuclear Technologies for Health (Intecnus), located in Bariloche, Argentina.
Interested in learning from Argentina’s experience in the implementation of its National Nuclear Medicine Plan (PNMN) with a view to promoting its oncology center project, the Reloncaví Health Service signed an alliance with the Institute of Nuclear Technologies for Health ( Intecnus) based in Bariloche.
The Institute of Nuclear Technologies for Health (Intecnus), located in San Carlos de Bariloche and inaugurated in December 2017 by the National Atomic Energy Commission (CNEA). This organization was the executor in Argentina of the PNMN.
In addition to human resources training and clinical research projects, Intecnus specializes in Nuclear Medicine and Radiotherapy, areas in which it has cutting-edge equipment for both diagnosis and treatment of a wide range of oncological, cardiac, neurological and endocrine pathologies, among others. Likewise, in these sectors it has highly trained professionals in Medicine, Medical Physics, Biomedical Engineering and Bioimage Production, among other profiles.
SERVICES
In Nuclear Medicine, Intecnus offers PET Service and Conventional Nuclear Medicine Service, in which its three hybrid equipment stands out, differential in the region: a PET-CT, a SPECT-CT and a PET-MR; The latter was the second installed in Latin America. This hybrid technology allows the anatomical (with tomography and MRI) and functional (with PET and SPECT) knowledge of the patient to be complemented in a single study.
In the field of Radiotherapy, the Argentine Institution is equipped with two linear accelerators for medical use for Teletherapy (External Radiotherapy) and with a shielded room in which a team for High Dose Rate Brachytherapy treatments (Internal Radiotherapy) is housed. . Since its launch in 2018, the Radiotherapy Service assisted more than 1600 patients diagnosed with breast cancer, prostate cancer, cervical cancer, and head and neck cancer, among other oncological pathologies.
In November 2023, patients referred from the Reloncaví Health Service began to receive care there. Until now, through Fonasa, almost 60 compatriots had access to these treatments last generation.
The agreement signed in October 2023 between Fonasa and Intecnus will allow the region’s health services to be prioritized over the next 5 years, both in the development of the Radiotherapy Center based in Puerto Montt, and in the training of excellent human resources. which will allow the Reloncaví Region to contain demand in the approach to oncological pathology as long as its own Center is operational.
If you are interested in receiving news published in Diario Futrono, register your email here
If you are going to use content from our newspaper (texts or simply data) in any media, blog or Social Networks, indicate the source, otherwise you will be incurring a crime sanctioned by Law No. 17,336, on Intellectual Property. The above does not apply to photographs and videos, since their reproduction for informational purposes is totally PROHIBITED.
